While the biological subtype in the patients with pathogenic variants of BRCA2 resembles distribution of sporadic breast cancers to a great extent, most breast cancers in pathogenic BRCA1 variant carriers have TNBC subtype [12]. This evidence concerns the gene BRCA2 and breast cancer.